...
首页> 外文期刊>Nature Communications >Hydro-Seq enables contamination-free high-throughput single-cell RNA-sequencing for circulating tumor cells
【24h】

Hydro-Seq enables contamination-free high-throughput single-cell RNA-sequencing for circulating tumor cells

机译:Hydro-Seq可为循环肿瘤细胞实现无污染的高通量单细胞RNA测序

获取原文
           

摘要

Molecular analysis of circulating tumor cells (CTCs) at single-cell resolution offers great promise for cancer diagnostics and therapeutics from simple liquid biopsy. Recent development of massively parallel single-cell RNA-sequencing (scRNA-seq) provides a powerful method to resolve the cellular heterogeneity from gene expression and pathway regulation analysis. However, the scarcity of CTCs and the massive contamination of blood cells limit the utility of currently available technologies. Here, we present Hydro-Seq, a scalable hydrodynamic scRNA-seq barcoding technique, for high-throughput CTC analysis. High cell-capture efficiency and contamination removal capability of Hydro-Seq enables successful scRNA-seq of 666 CTCs from 21 breast cancer patient samples at high throughput. We identify breast cancer drug targets for hormone and targeted therapies and tracked individual cells that express markers of cancer stem cells (CSCs) as well as of epithelial/mesenchymal cell state transitions. Transcriptome analysis of these cells provides insights into monitoring target therapeutics and processes underlying tumor metastasis.
机译:以单细胞分辨率进行的循环肿瘤细胞(CTC)分子分析为通过简单的液体活检进行癌症诊断和治疗提供了广阔的前景。大规模并行单细胞RNA测序(scRNA-seq)的最新发展提供了一种从基因表达和途径调控分析解决细胞异质性的有力方法。但是,四氯化碳的缺乏和血细胞的大量污染限制了目前可用技术的实用性。在这里,我们介绍Hydro-Seq,一种可扩展的水动力scRNA-seq条形码技术,用于高通量CTC分析。 Hydro-Seq的高细胞捕获效率和去除污染物的能力使高通量的21个乳腺癌患者样品中的666个CTC成功地进行了scRNA-seq。我们确定荷尔蒙和靶向疗法的乳腺癌药物靶标,并跟踪表达癌症干细胞(CSC)以及上皮/间充质细胞状态转换标记的单个细胞。这些细胞的转录组分析提供了对监测目标疗法和潜在肿瘤转移过程的见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号